CC BY 4.0 · Surg J (N Y) 2021; 07(02): e83-e91
DOI: 10.1055/s-0041-1725155
Review Article

The Impact of COVID-19 Disease on Urology Practice

Mohamad Moussa
1   Department of Urology, Al Zahraa Hospital & Lebanese University, Beirut, Lebanon
,
Mohamed Abou Chakra
2   Department of Urology, Lebanese University, Beirut, Lebanon
,
Athanasios G. Papatsoris
3   2nd Department of Urology, School of Medicine, National and Kapodistrian University of Athens, Sismanoglio Hospital, Athens, Greece
,
Athanasios Dellis
4   Department of Urology/General Surgery, Areteion Hospital, Athens, Greece
› Author Affiliations
Funding None.

Abstract

The diagnosis and timely treatment of cancer patients should not be compromised during an infectious disease pandemic. The pandemic of coronavirus disease 2019 (COVID-19) has serious implications on urology practice and raises particular questions for urologists about the management of different conditions. It was recommended to cancel most of the elective urological surgeries. Urological cancers surgeries that should be prioritized are radical cystectomy for selective tumors, orchiectomy for suspected testicular tumors, nephrectomy for c T3 + , nephroureterectomy for high-grade disease, and radical adrenalectomy for tumors >6 cm or adrenal carcinoma. Most prostatectomies can be delayed without compromising the survival rate of patients. Urological emergencies should be treated adequately even during this pandemic. There is a potential risk of coronavirus diffusion during minimally invasive procedures performed. It is crucial to use specific precautions when urologists performed those type of surgeries. It was also recommended to suspend the kidney transplantation program during the COVID-19 pandemic except for specific cases. In this review, we discussed the triage of urological surgeries, the risk of minimally invasive urological procedure, the kidney transplantation challenges, the systemic therapies, intravesical instillation of Bacillus Calmette-Guérin (BCG), endourology, teleconferencing, and telemedicine application in urology during the COVID-19 pandemic.



Publication History

Received: 19 July 2020

Accepted: 12 January 2021

Article published online:
03 June 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc 2020; 83 (03) 217-220
  • 2 Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020; 55 (05) 105955
  • 3 Guo YR, Cao QD, Hong ZS. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Mil Med Res 2020; 7 (01) 11
  • 4 Wong J, Goh QY, Tan Z. et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020; 67 (06) 732-745
  • 5 Odor PM, Neun M, Bampoe S. et al. Anaesthesia and COVID-19: infection control. Br J Anaesth 2020; 125 (01) 16-24
  • 6 Stahel PF. How to risk-stratify elective surgery during the COVID-19 pandemic?. Patient Saf Surg 2020; 14: 8
  • 7 Coccolini F, Perrone G, Chiarugi M. et al. Surgery in COVID-19 patients: operational directives. World J Emerg Surg 2020; 15 (01) 25
  • 8 Heinze A, Umari P, Basulto-Martínez M. et al. Impact of COVID-19 on clinical and academic urological practice: a survey from European Association of Urology Section of Urotechnology. Eur Urol Open Sci 2020; 21: 22-28
  • 9 Kriegmair MC, Kowalewski KF, Lange B. et al. Urologie in der Corona-Virus-Pandemie—Leitfaden 4/20 Urology in the corona-virus pandemic-a guideline 4/20. Urologe A 2020; 59 (04) 442-449
  • 10 Naspro R, Da Pozzo LF. Urology in the time of corona. Nat Rev Urol 2020; 17 (05) 251-253
  • 11 Ahmed K, Hayat S, Dasgupta P. Global challenges to urology practice during the COVID-19 pandemic. BJU Int 2020; 125 (06) E5-E6
  • 12 Stensland KD, Morgan TM, Moinzadeh A. et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020; 77 (06) 663-666
  • 13 Spinoit AF, Haid B, Hiess M. et al. Impact of the COVID-19 pandemic on paediatric urology practice in Europe: a reflection from the European Association of Urology Young Academic Urologists. Eur Urol 2020; 78 (01) 122-124
  • 14 Cocci A, Presicce F, Russo GI, Cacciamani G, Cimino S, Minervini A. How sexual medicine is facing the outbreak of COVID-19: experience of Italian urological community and future perspectives. Int J Impot Res 2020; 32 (05) 480-482
  • 15 Katz EG, Stensland KD, Mandeville JA. et al. Triaging office based urology procedures during the COVID-19 pandemic. J Urol 2020; 204 (01) 9-10
  • 16 Ficarra V, Novara G, Abrate A. et al; Research Urology Network (RUN). Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol 2020; 72 (03) 369-375
  • 17 Cestari A, White WM. A tale of two cities: insight and practical considerations during the COVID pandemic. Urology 2020; 142: 38-41
  • 18 Morlacco A, Motterle G, Zattoni F. The multifaceted long-term effects of the COVID-19 pandemic on urology. Nat Rev Urol 2020; 17 (07) 365-367
  • 19 Pak JS, Sayegh CI, Smigelski MB, McKiernan JM, Cooper KL. A urology department's experience at the epicenter of the COVID-19 pandemic. Urology 2020; 144: 4-8
  • 20 Hevia V, Lorca J, Hevia M. et al. COVID-19 Pandemic: Impact and rapid reaction of urology. Actas Urol Esp 2020; 44 (07) 450-457
  • 21 de la Reza MT, Autrán-Gómez AM, Tardío GU, Bolaños JA, Rivero JCG. Emergency surgery in urology during the COVID-19 pandemic. Int Braz J Urol 2020; 46 (Suppl. 01) 201-206
  • 22 Amparore D, Campi R, Checcucci E. et al. Forecasting the future of urology practice: a comprehensive review of the recommendations by International and European Associations on priority procedures during the COVID-19 pandemic. Eur Urol Focus 2020; 6 (05) 1032-1048
  • 23 Al-Shamsi HO, Alhazzani W, Alhuraiji A. et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist 2020; 25 (06) e936-e945
  • 24 Schrag D, Hershman DL, Basch E. Oncology Practice During the COVID-19 Pandemic. JAMA 2020; 323 (20) 2005-2006
  • 25 Campi R, Amparore D, Capitanio U. et al. Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres. Eur Urol 2020; 78 (01) 11-15
  • 26 Oderda M, Roupret M, Marra G. et al. The impact of COVID-19 outbreak on uro-oncological practice across Europe: which burden of activity are we facing ahead?. Eur Urol 2020; 78 (01) 124-126
  • 27 Marandino L, Di Maio M, Procopio G, Cinieri S, Beretta GD, Necchi A. The shifting landscape of genitourinary oncology during the COVID-19 pandemic and how Italian Oncologists reacted: results from a National Survey. Eur Urol 2020; 78 (01) e27-e35
  • 28 Zaorsky NG, Yu JB, McBride SM. et al. Prostate cancer radiation therapy recommendations in response to COVID-19. Adv Radiat Oncol 2020; 5 (04) 659-665
  • 29 Obek C, Doganca T, Argun OB, Kural AR. Management of prostate cancer patients during COVID-19 pandemic. Prostate Cancer Prostatic Dis 2020; 23 (03) 398-406
  • 30 Ribal MJ, Cornford P, Briganti A. et al; GORRG Group, EAU Section Offices and the EAU Guidelines Panels. European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020; 78 (01) 21-28
  • 31 Lalani AA, Chi KN, Heng DYC. et al. Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Can Urol Assoc J 2020; 14 (05) E154-E158
  • 32 Dovey Z, Mohamed N, Gharib Y. et al. Impact of COVID-19 on prostate cancer management: guidelines for urologists. Eur Urol Open Sci 2020; 20: 1-11
  • 33 Cattrini C, Bersanelli M, Latocca MM, Conte B, Vallome G, Boccardo F. Sex hormones and hormone therapy during COVID-19 pandemic: implications for patients with cancer. Cancers (Basel) 2020; 12 (08) 2325
  • 34 Patel VG, Zhong X, Liaw B. et al. Does androgen deprivation therapy protect against severe complications from COVID-19?. Ann Oncol 2020; 31 (10) 1419-1420
  • 35 Wang T, Liu S, Joseph T, Lyou Y. Managing Bladder cancer care during the COVID-19 pandemic using a team-based approach. J Clin Med 2020; 9 (05) 1574
  • 36 Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM. Bladder cancer at the time of COVID-19 outbreak. Int Braz J Urol 2020; 46 (Suppl. 01) 62-68
  • 37 Busetto GM, Porreca A, Del Giudice F. et al. SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features?. Urol Int 2020; 104 (7-8): 510-522
  • 38 Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and its impact on genitourinary malignancies. Indian J Urol 2020; 36 (03) 163-170
  • 39 Carneiro A, Wroclawski ML, Nahar B. et al. Impact of the COVID-19 pandemic on the urologist's clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period. Int Braz J Urol 2020; 46 (04) 501-510
  • 40 Nappi L, Ottaviano M, Rescigno P. et al; Italian Germ Cell Cancer Group (IGG), ERN-EURACAN Domain G3, Genitourinary Medical Oncologists of Canada (GUMOC). Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers. Oncologist 2020; 25 (10) e1509-e1515
  • 41 Hevia V, Linares-Espinós E, Alonso-Gordoa T. et al. Renal cell carcinoma and COVID-19 pandemia: management strategies adapted to current practice. Arch Esp Urol 2020; 73 (05) 360-366
  • 42 Zequi SC, Abreu D. Consideration in the management of renal cell carcinoma during the COVID-19 pandemic. Int Braz J Urol 2020; 46 (Suppl. 01) 69-78
  • 43 Compérat E. What does COVID-19 mean for the pathology-urology interaction?. Eur Urol 2020; 78 (01) e43-e44
  • 44 Gillessen S, Powles T. Advice regarding systemic therapy in patients with urological cancers during the COVID-19 pandemic. Eur Urol 2020; 77 (06) 667-668
  • 45 Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy 2020; 12 (05) 269-273
  • 46 Hegarty PK, Sfakianos JP, Giannarini G, DiNardo AR, Kamat AM. COVID-19 and Bacillus Calmette-Guérin: what is the link?. Eur Urol Oncol 2020; 3 (03) 259-261
  • 47 Lenfant L, Seisen T, Loriot Y, Rouprêt M. Adjustments in the use of intravesical instillations of Bacillus Calmette-Guérin for high-risk non-muscle-invasive bladder cancer during the COVID-19 pandemic. Eur Urol 2020; 78 (01) 1-3
  • 48 Desouky E. Intravesical BCG amid COVID-19: to give or not to give?. Turk J Urol 2020; 46 (04) 274-276
  • 49 Akan S, Ediz C, Kızılkan YE, Alcin A, Tavukcu HH, Yilmaz O. COVID-19 infection threat in patients with high-risk non-muscle invasive bladder cancer receiving intravesical BCG therapy. Int J Clin Pract 2020; e13752 DOI: 10.1111/ijcp.13752.
  • 50 Mohamed Hussein AAR, Salem MR, Salman S. et al. Correlation between COVID-19 case fatality rate and percentage of BCG vaccination: is it true the vaccine is protective?. Egypt J Bronchol 2020; 14 (01) 25
  • 51 Waterhouse JV, Hull JH, Linch M. Corticosteroids for urological cancer care during coronavirus disease 2019. Treat or not to treat?. Eur Urol 2020; 78 (01) 9-10
  • 52 Vigneswaran Y, Prachand VN, Posner MC, Matthews JB, Hussain M. What is the appropriate use of laparoscopy over open procedures in the current COVID-19 climate?. J Gastrointest Surg 2020; 24 (07) 1686-1691
  • 53 Bogani G, Raspagliesi F. Minimally invasive surgery at the time of COVID-19: the OR staff needs protection. J Minim Invasive Gynecol 2020; 27 (05) 1221
  • 54 Novara G, Giannarini G, De Nunzio C, Porpiglia F, Ficarra V. Risk of SARS-CoV-2 diffusion when performing minimally invasive surgery during the COVID-19 pandemic. Eur Urol 2020; 78 (01) e12-e13
  • 55 Motterle G, Dal Moro F, Zanovello N. et al. Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy. J Robot Surg 2020; 14 (06) 909-911
  • 56 Zampolli HC, Rodriguez AR. Laparoscopic and robotic urology surgery during global pandemic COVID19. Int Braz J Urol 2020; 46 (Suppl. 01) 215-221
  • 57 Porter J, Blau E, Gharagozloo F. et al. Society of robotic surgery review: recommendations regarding the risk of COVID-19 transmission during minimally invasive surgery. BJU Int 2020; 126 (02) 225-234
  • 58 Ling Y, Xu SB, Lin YX. et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020; 133 (09) 1039-1043
  • 59 Puliatti S, Eissa A, Eissa R. et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int 2020; 125 (06) E7-E14
  • 60 Proietti S, Gaboardi F, Giusti G. Endourological stone management in the era of the COVID-19. Eur Urol 2020; 78 (02) 131-133
  • 61 Antonucci M, Recupero SM, Marzio V. et al. The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis. Actas Urol Esp 2020; 44 (09) 611-616
  • 62 Flammia S, Salciccia S, Tufano A, Busetto GM, Ricciuti GP, Sciarra A. How urinary stone emergencies changed in the time of COVID-19?. Urolithiasis 2020; 48 (05) 467-469
  • 63 Davenport K, Waine E. The role of non-steroidal anti-inflammatory drugs in renal colic. Pharmaceuticals (Basel) 2010; 3 (05) 1304-1310
  • 64 Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?. Ecancermedicalscience 2020; 14: 1023
  • 65 Martino F, Plebani M, Ronco C. Kidney transplant programmes during the COVID-19 pandemic. Lancet Respir Med 2020; 8 (05) e39
  • 66 Gandolfini I, Delsante M, Fiaccadori E. et al. COVID-19 in kidney transplant recipients. Am J Transplant 2020; 20 (07) 1941-1943
  • 67 Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int 2020; 97 (06) 1076-1082
  • 68 López V, Vázquez T, Alonso-Titos J. et al; Grupo de Estudio GREAT (Grupo Español de Actualizaciones en Trasplante). Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients. Nefrologia 2020; 40 (03) 265-271
  • 69 Coates PT, Wong G, Drueke T, Rovin B, Ronco P. Associate Editors, for the Entire Editorial Team. Early experience with COVID-19 in kidney transplantation. Kidney Int 2020; 97 (06) 1074-1075
  • 70 Ahn C, Amer H, Anglicheau D. et al. Global transplantation COVID report March 2020. Transplantation 2020; 104 (10) 1974-1983
  • 71 Johnson KM, Belfer JJ, Peterson GR, Boelkins MR, Dumkow LE. Managing COVID-19 in renal transplant recipients: a review of recent literature and case supporting corticosteroid-sparing immunosuppression. Pharmacotherapy 2020; 40 (06) 517-524
  • 72 González J, Ciancio G. Early experience with COVID-19 in kidney transplantation recipients: update and review. Int Braz J Urol 2020; 46 (Suppl. 01) 145-155
  • 73 Porpiglia F, Checcucci E, Autorino R. et al. Traditional and virtual congress meetings during the COVID-19 pandemic and the post-COVID-19 era: is it time to change the paradigm?. Eur Urol 2020; 78 (03) 301-303
  • 74 Khusid JA, Sullivan JF, Esdaille AR, Khargi R, Shields JM. SUNY Downstate Health Sciences University Urology Team. Role of the urologist during a pandemic: early experience in practicing on the front lines in Brooklyn, New York. Eur Urol 2020; 78 (01) e36-e37
  • 75 Gadzinski AJ, Gore JL, Ellimoottil C, Odisho AY, Watts KL. Implementing telemedicine in response to the COVID-19 pandemic. J Urol 2020; 204 (01) 14-16
  • 76 Boehm K, Ziewers S, Brandt MP. et al. Telemedicine online visits in urology during the COVID-19 pandemic-potential, risk factors, and patients' perspective. Eur Urol 2020; 78 (01) 16-20
  • 77 Pinar U, Anract J, Perrot O. et al. Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic. World J Urol 2020; 1-6 DOI: 10.1007/s00345-020-03432-4.